AACC's Go-To Conclave for Networking, Research, Technology
By CLN Stat Posted on 29 Jul 2019 |
(Photo courtesy of AACC)
The 71st AACC Annual Scientific Meeting & Clinical Lab Expo offers something for everyone in clinical laboratory medicine, showcasing the latest in precision medicine, novel biomarker research, the opioid epidemic and journals hot topics, plus a host of networking events and technology game-changers at the Expo.
Janetta Bryksin, PhD, DABCC, co-director of clinical chemistry and director of special chemistry at Emory Healthcare in Atlanta, is among the many enthusiastic AACC members who plan to attend this year’s meeting in Anaheim, California. “If there is one conference to go to each year, it’ll be the AACC Annual Scientific Meeting for me,” Bryksin told CLN Stat. “It offers many learning and networking opportunities through scientific sessions, Expo presenters, and local section and division meetings, as well as informal mixer meetings.”
Joshua Akin, clinical laboratory scientist at UC San Diego Health System Center for Advanced Laboratory Medicine, is another AACC member gearing up for the ASM. “It’s a great opportunity to brush up on recent research and new technology, as well as current trends and emerging issues in clinical labs,” Akin said.
Bryksin and Akin neatly sum up the top five reasons for attending this yearly conclave:
The 71st AACC Annual Scientific Meeting & Clinical Lab Expo takes place on August 4–8 in Anaheim, California. AACC members receive a discount on registration. Come join the conclave in sunny Southern California to network and learn about the latest breakthroughs in laboratory scientists from world-renowned speakers.
Janetta Bryksin, PhD, DABCC, co-director of clinical chemistry and director of special chemistry at Emory Healthcare in Atlanta, is among the many enthusiastic AACC members who plan to attend this year’s meeting in Anaheim, California. “If there is one conference to go to each year, it’ll be the AACC Annual Scientific Meeting for me,” Bryksin told CLN Stat. “It offers many learning and networking opportunities through scientific sessions, Expo presenters, and local section and division meetings, as well as informal mixer meetings.”
Joshua Akin, clinical laboratory scientist at UC San Diego Health System Center for Advanced Laboratory Medicine, is another AACC member gearing up for the ASM. “It’s a great opportunity to brush up on recent research and new technology, as well as current trends and emerging issues in clinical labs,” Akin said.
Bryksin and Akin neatly sum up the top five reasons for attending this yearly conclave:
- 5 Plenary Sessions: Clinical genomics, biomarker discoveries, and extreme molecular diagnostics are among the cutting-edge topics being presented by world-class researchers. Another fascinating session will explore translating gene-disease associations to brain circuitry.
- 4(0)+ Special Events and Socials: Participants have 40 events to choose from, including education on shared interest topics and mixers hosted by AACC groups and divisions. For the last few years, the Society for Young Clinical Laboratorians (SYCL) workshops have been the highlight of Bryksin’s Annual Scientific Meeting experience. “SYCL workshops are always very engaging, educational, and fun! I’m looking forward to learning about the impact of technology utilization in laboratory medicine at the SYCL workshop this year,” she said.
Workshops and networking events create long-lasting memories for attendees. Akin fondly recalls a local AACC section networking event at the 2018 Annual Scientific Meeting in San Diego. Participants met at Petco Park and “ate hot dogs, caught up with old colleagues, and watched the San Diego Padres beat the Pittsburgh Pirates,” he recalled. - 3 Days of the Clinical Lab Expo: There’s no better resource for cutting-edge laboratory technology than the Clinical Lab Expo. With more than 850 exhibiting companies and 200 new product introductions, this event rightly claims the title as the world’s largest exposition for clinical laboratory products and services. Visiting the Expo for the first time, “it was so vastly, overwhelmingly huge with thousands of people all discussing the latest technologies, I didn’t know where to start!” said Alec Saitman, PhD, DABCC (CC, TC), director of toxicology and special chemistry at Providence Regional Laboratories in Portland, Oregon. Saitman not only will be attending this year’s Annual Scientific Meeting but also actively participating, as a SYCL workshop instructor and as a member of the CLN Daily editorial board, covering the meeting for the event’s official publication.
- 2(0,000) Lab Medicine Attendees: There’s no better place for a clinical lab professional to make connections with more than 20,000 expected for this year’s meeting. “I always enjoy chatting with vendors and laboratory professionals from all different walks of laboratory medicine,” said Akin.
- 1 Disruptive Tech Award Winner: AACC’s Disruptive Technology Award recognizes innovative testing solutions that improve patient care through diagnostic performance or access to high-quality testing. Developers of precision and personalized medicine diagnostics headline this year’s award. Three finalist teams will present data on their technologies and one team will walk away with a cash prize.
The 71st AACC Annual Scientific Meeting & Clinical Lab Expo takes place on August 4–8 in Anaheim, California. AACC members receive a discount on registration. Come join the conclave in sunny Southern California to network and learn about the latest breakthroughs in laboratory scientists from world-renowned speakers.
Latest AACC 2019 News
- Instrumentation Laboratory Presents New IVD Testing System
- Quidel Welcomes Newest Member of Triage Family
- ERBA Mannheim Unveils Next-Generation Automation
- Roche Demonstrates How Health Networks Are Driving Change in Labs and Beyond
- BioMérieux Spotlights Diagnostic Solutions in Use of Antibiotics
- Thermo Shows New Clinical Innovations
- Randox Launches New Innovations
- Streck Introduces Three New Antibiotic Resistance Detection Kits
- EKF Diagnostics Highlights Assay for Diabetes Patient Monitoring
- Sysmex America Exhibits New Products, Automation and Quality Solutions
- BBI Solutions Showcases Mobile Solutions Capabilities at AACC 2019
- MedTest Dx Releases New Product Line for Drugs of Abuse Testing
- Mesa Biotech Launches Molecular Test System at AACC 2019
- Ortho Clinical Diagnostics Highlights Groundbreaking Lab Technology
- Abbott Diagnostics Exhibits POC Diagnostics Solutions at AACC
- Beckman Coulter Demonstrates Latest Innovations in Lab Medicine
Channels
Clinical Chemistry
view channel
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
Accurately monitoring drug levels in the blood is essential for effective treatment, particularly in the management of cardiovascular diseases. Traditional techniques for monitoring blood drug levels often... Read more
Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients.... Read more
Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. However, detecting proteins at extremely low ... Read moreMolecular Diagnostics
view channel
Portable Blood-Based Device Detects Colon Cancer
Colon cancer is the second leading cause of cancer-related deaths in the U.S., yet it is highly treatable when detected at an early stage. Traditional colonoscopy screenings, although effective, are unpleasant,... Read more
New DNA Test Diagnoses Bacterial Infections Faster and More Accurately
Antimicrobial resistance has emerged as a significant global health threat, causing at least one million deaths annually since 1990. The Global Research on Antimicrobial Resistance (GRAM) Project warns... Read more
Innovative Bio-Detection Platform Improves Early Cancer Screening and Monitoring
Cancer remains one of the leading causes of death globally, underscoring the critical need for more advanced, efficient, and early detection methods. Circulating tumor cells (CTCs) are cells that have... Read more
Blood Test Could Help More Women Survive Aggressive Triple Negative Breast Cancer
Cancer research shows that over 90% of women diagnosed with breast cancer at its earliest stage survive for five years or more. However, this survival rate dramatically decreases to just 30% when the cancer... Read moreHematology
view channel
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
WBC Count Could Predict Severity of COVID-19 Symptoms
The global health crisis caused by the SARS-CoV-2 virus continues to impact millions of people worldwide, with many experiencing persistent symptoms months after the initial diagnosis. Cognitive impairment... Read more
New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
Accurate platelet count testing is a significant challenge for laboratories. Inaccurate results can lead to misdiagnosis, missed diagnoses, and delayed treatment for a variety of potentially fatal conditions,... Read more
Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
Heparin-induced thrombocytopenia (HIT), a serious side effect of the blood thinner heparin, is difficult to diagnose because thrombocytopenia, or low platelet count, can be caused by a variety of factors... Read moreImmunology
view channelCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read more
Rapid PCR Testing in ICU Improves Antibiotic Stewardship
A collaborative study led by the University of Plymouth (Devon, UK) has shown that rapid polymerase chain reaction (PCR) testing in the intensive care unit (ICU) improved antibiotic stewardship compared... Read morePathology
view channel
New Test Diagnoses High-Risk Childhood Brain Tumors
Medulloblastoma, which originates in the cerebellum, the rear part of the brain, is the most prevalent malignant brain tumor in children and is notoriously difficult to diagnose. Currently, identifying... Read more
Informatics Solution Elevates Laboratory Efficiency and Patient Care
QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories.... Read more
Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread
Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis
Tissue analysis typically involves a pathologist reviewing scanned digital slides from a patient’s intestinal sample and marking specific areas, such as those where cancerous and related tissues are present.... Read moreTechnology
view channel
POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
Cardiovascular diseases continue to be the leading cause of death worldwide, accounting for over 19 million fatalities annually. Early detection of myocardial infarction (MI), commonly known as a heart... Read more
Study Explores Impact of POC Testing on Future of Diagnostics
In today’s rapidly changing world, having quick and accurate access to medical information is more crucial than ever. Point-of-Care Diagnostics (PoC-D) and Point-of-Care Testing (PoC-T) are making this... Read more
Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
Cancer biomarkers are valuable tools for early diagnosis as their concentration in body fluids, such as serum, can be measured to detect the disease at an earlier stage. Additionally, serum levels of these... Read moreIndustry
view channel
CACLP 2025 Unites Global Innovators in IVD Industry
CACLP (Shanghai, China) will be holding the 22nd China International In Vitro Diagnostic Expo, the largest and most influential gathering of the IVD industry in China, 22-24 March 2025 at the Hangzhou... Read more
Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
Bio-Rad Laboratories (Hercules, CA, USA) has entered into a binding offer to purchase all equity interests in Stilla Technologies (Villejuif, France). The acquisition remains subject to consultation with... Read more